This is the authors' abstract. We don't add key points for this paper.
Introduction: The detection of tumor markers has become an important non-invasive detection method for early detection, diagnosis, and prognosis and treatment of tumors. Methods: (ferriferrous oxide/α-iron trioxide, FOαIT) magnetic heterogeneous nanorods fabricated with CTAB as a restricted growth agent for sensitive detection of heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1). Firstly, FOαIT@Au magnetic nanocomposites (MNCs) were prepared via the hydrothermal and calcination-reduction process with Au nanoparticles (AuNPs) modified on the surface. With the help of Au-S bonding, ssDNA/BC15 was immobilized to form FOαIT@Au/ssDNA/BC15. To avoid the effect of nonspecific sites to the detection, BSA was employed to block them and form FOαIT@Au/ssDNA/BC15/BSA nano-biosensors. Utilizing the stronger linkage force of hnRNP A1 with BC15 than that of FOαIT@Au/ssDNA, the sensitive and accurate detection of hnRNP A1 was realized. Results and Discussion: The nano-biosensors revealed a decent linear relationship with a lower LOD of 0.103 pg/mL, higher sensitivity, excellent selectivity, satisfactory repeatability (RSD ≤1.55%), dependable long-term stability, and the accurate detection of spiked samples, revealing the promising application prospect in the clinical examination.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: